🇺🇸 FDA
Patent

US 10660918

Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell

granted A61KA61K2035/124A61K35/28

Quick answer

US patent 10660918 (Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell) held by China Medical University expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2035/124, A61K35/28, A61K38/179, A61K38/1858